XML 80 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue from Contract with Customer (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Jan. 01, 2023
Jan. 02, 2022
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,750,571 $ 3,311,822 $ 3,827,808
Contract with Customer, Asset, Net, Current 52,648 56,631  
Contract with Customer, Liability, Current (22,504) (30,133)  
Contract with Customer, Asset and Liability [Abstract]      
Contract with Customer, Asset, Net, Current 52,648 56,631  
Contract with Customer, Liability, Current (22,504) (30,133)  
Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,215,613 1,662,643 1,806,672
Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 747,024 831,811 1,216,810
Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 787,934 817,368 804,326
Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,458,231 2,018,913 2,931,939
Diagnostics [Member] | Customer Concentration Risk [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax   330,700 638,600
Diagnostics [Member] | Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 543,875 979,473 1,362,213
Diagnostics [Member] | Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 438,457 534,343 982,476
Diagnostics [Member] | Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 475,899 505,097 587,250
Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 1,292,340 1,292,909 895,869
Life Sciences [Member] | Americas [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 671,738 683,170 444,459
Life Sciences [Member] | Europe [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 308,567 297,468 234,334
Life Sciences [Member] | Asia [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 312,035 312,271 217,076
Life Sciences reagents [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 732,789 691,344 399,518
Life Sciences reagents [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Life Sciences reagents [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 732,789 691,344 399,518
Life Sciences instruments [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 381,262 405,554 329,584
Life Sciences instruments [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Life Sciences instruments [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 381,262 405,554 329,584
Life Sciences software [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 178,289 196,011 166,767
Life Sciences software [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Life Sciences software [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 178,289 196,011 166,767
Reproductive health [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 501,302 516,574 514,863
Reproductive health [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 501,302 516,574 514,863
Reproductive health [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Applied genomics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 228,443 393,602 619,357
Applied genomics [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 228,443 393,602 619,357
Applied genomics [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0
Immunodiagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 728,486 1,108,737 1,797,719
Immunodiagnostics [Member] | Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 728,486 1,108,737 1,797,719
Immunodiagnostics [Member] | Life Sciences [Member]      
Disaggregation of Revenue [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 0 $ 0 $ 0